Cerebral venous thrombosis
Cerebral Venous Thrombosis Cerebral venous thrombosis is characterized by infarction with
focal neurologic deficits and increased intracranial pressure. As a very rare complication of …
focal neurologic deficits and increased intracranial pressure. As a very rare complication of …
Hemorrhagic stroke
A Montaño, DF Hanley, JC Hemphill III - Handbook of clinical neurology, 2021 - Elsevier
Hemorrhagic stroke comprises about 20% of all strokes, with intracerebral hemorrhage
(ICH) being the most common type. Frequency of ICH is increased where hypertension is …
(ICH) being the most common type. Frequency of ICH is increased where hypertension is …
Diagnosis and management of cerebral venous thrombosis: a Scientific Statement from the American Heart Association
Cerebral venous thrombosis accounts for 0.5% to 3% of all strokes. The most vulnerable
populations include young individuals, women of reproductive age, and patients with a …
populations include young individuals, women of reproductive age, and patients with a …
Cerebral venous thrombosis: a practical guide
All neurologists need to be able to recognise and treat cerebral venous thrombosis (CVT). It
is difficult to diagnose, partly due to its relative rarity, its multiple and various clinical …
is difficult to diagnose, partly due to its relative rarity, its multiple and various clinical …
[HTML][HTML] Cerebral vein thrombosis with vaccine-induced immune thrombotic thrombocytopenia
In the spring of 2021, reports of rare and unusual venous thrombosis in association with the
ChAdOx1 and Ad26. COV2. S adenovirus-based coronavirus vaccines led to a brief …
ChAdOx1 and Ad26. COV2. S adenovirus-based coronavirus vaccines led to a brief …
Cerebral venous sinus thrombosis in the COVID-19 pandemic
CB Medicherla, RA Pauley, A de Havenon… - Journal of Neuro …, 2020 - journals.lww.com
Background: Recent studies have noted concern for increased thromboembolic events in
the setting of Coronavirus Disease 2019 (COVID-19). Cerebral venous sinus thrombosis …
the setting of Coronavirus Disease 2019 (COVID-19). Cerebral venous sinus thrombosis …
Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update
CM Schirmer, KR Bulsara, F Al-Mufti… - Journal of …, 2023 - jnis.bmj.com
Background Antiplatelet and antithrombotic medication management before, during, and
after neurointerventional procedures has significant practice variation. This document …
after neurointerventional procedures has significant practice variation. This document …
Endovascular treatment for cerebral venous thrombosis: current status, challenges, and opportunities
M Goyal, J Fladt, JM Coutinho… - Journal of …, 2022 - jnis.bmj.com
Cerebral venous thrombosis (CVT) mostly affects young people. So far, endovascular
treatment (EVT) has not been shown to be beneficial in CVT, partially because venous EVT …
treatment (EVT) has not been shown to be beneficial in CVT, partially because venous EVT …
[HTML][HTML] Endovascular treatment of intracranial vein and venous sinus thrombosis—a systematic review
P Buecke, V Hellstern, A Cimpoca, JE Cohen… - Journal of clinical …, 2022 - mdpi.com
Background: Cerebral venous sinus or vein thromboses (SVT) are treated with heparin
followed by oral anticoagulation. Even after receiving the best medical treatment, numerous …
followed by oral anticoagulation. Even after receiving the best medical treatment, numerous …
[HTML][HTML] Updates in cerebral venous thrombosis
A Alimohammadi, DJ Kim, TS Field - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Cerebral venous thrombosis (CVT) is a rare cause of stroke that
most commonly affects younger women. Here, we review new literature relevant to the …
most commonly affects younger women. Here, we review new literature relevant to the …